- Home
- KNSA vs ZGN Comparison
KNSA vs ZGN Comparison
Compare KNSA & ZGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KNSA | ZGN |
|---|---|---|
| Founded | 2015 | 1910 |
| Country | United Kingdom | Italy |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.0B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KNSA | ZGN |
|---|---|---|
| Price | $51.58 | $14.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $60.86 | $11.28 |
| AVG Volume (30 Days) | 461.7K | ★ 1.1M |
| Earning Date | 04-28-2026 | 03-20-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $677,564,000.00 | N/A |
| Revenue This Year | $37.48 | $5.17 |
| Revenue Next Year | $17.87 | $7.89 |
| P/E Ratio | $182.48 | ★ $25.94 |
| Revenue Growth | ★ 60.09 | N/A |
| 52 Week Low | $26.27 | $7.61 |
| 52 Week High | $59.87 | $15.44 |
Technical Indicators
Market Signals| Indicator | KNSA | ZGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 66.58 |
| Support Level | $44.95 | $9.89 |
| Resistance Level | $59.87 | N/A |
| Average True Range (ATR) | 1.93 | 0.54 |
| MACD | -0.24 | -0.02 |
| Stochastic Oscillator | 52.85 | 81.06 |
Price Performance
Historical ComparisonAbout KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of revenue from the Zegna segment.